Ochre Bio brings together an incredible Scientific Strategy Board

Oct 28, 2022

Ochre Bio has announced their Scientific Strategy Board. This group of brilliant minds recently spent a day together in New York, to talk through Ochre’s scientific approach and future planning.

  • Sangeeta Bhatia – Wilson Professor of Engineering, MIT
  • Chinweike Ukomadu – SVP & Head of GI Therapeutic Area Unit, Takeda
  • Chas Bountra – Pro Vice Chancellor for Innovation & Professor of Translational Medicine, Oxford University
  • Scott Friedman – Professor and Chief, Division of Liver Diseases, Mount Sinai
  • Troy Dale – Head of Strategic Partnerships Unit, Novartis
  • Joel Dudley – Partner at IE; Former CSO Tempus Labs
  • Michael Hodges – Former CMO and Head of Development, Santaris Pharmaceuticals
  • Leanne Hodson – Professor of Metabolic Physiology, Oxford University
  • Eduardo Bruno Martins – CMO, Sagimet; Former VP of Clinical Development, Allergan/Abbvie
  • Alex K. Shalek – Associate Professor, MIT (and long time Ochre Bio sympathiser)

Watch some of the SSB members’ comments here!